Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China.

Qiao LiuPeng LuYe Shen Changwei LiJianming WangLimei ZhuWei LuLeonardo Martinez

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.

Keyphrases

coronavirus disease
mycobacterium tuberculosis
pulmonary tuberculosis
hiv aids
south africa
adverse drug
respiratory syndrome coronavirus
emergency department
sars cov
antiretroviral therapy
hiv infected
combination therapy
smoking cessation